Evidence-based approach to lymph node assessment and targeted axillary dissection
Evidence-based approach to lymph node assessment and targeted axillary dissection
Moving to the future: Artificial intelligence in surgery
Imaging advances for breast surgery
Personalised risk-stratified breast cancer screening for BRCA germline mutations and other genes
The 2022 OncoAlert Colloquium Day 6: EONS Sessions
The 2022 OncoAlert Colloquium Day 5: GI Oncology
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology
The 2022 OncoAlert Colloquium Day 3: Lung Cancer
The 2022 OncoAlert Colloquium Day 2: GU Oncology
The 2022 OncoAlert Colloquium Day 1: Breast Cancer
Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery
HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC